Results 231 to 240 of about 50,591 (247)
Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US. [PDF]
Ophthalmol TherKuznik A +5 more
europepmc +1 more source
The diagnostic value of platelet-to-neutrophil ratio in diabetic macular edema. [PDF]
BMC OphthalmolSun H, Li Y, Liu S, Pan C, Li D, Zhou X.
europepmc +1 more source
Aqueous Humor Proteome Associated with Incomplete Anti-VEGF Response in Diabetic Macular Edema
Lasse Jørgensen Cehofski +7 more
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Disease-a-Month, 2021
Diabetic retinopathy (DR) is a leading cause of preventable blindness world-wide. Diabetic macular edema (DME) is the most common cause of moderate vision loss in patients with diabetes. Although treatments for DME have improved significantly over the past decades, the burden of this disease remains high for patients and the healthcare system alike ...
Melissa, Ixcamey, Camille, Palma
+6 more sources
Diabetic retinopathy (DR) is a leading cause of preventable blindness world-wide. Diabetic macular edema (DME) is the most common cause of moderate vision loss in patients with diabetes. Although treatments for DME have improved significantly over the past decades, the burden of this disease remains high for patients and the healthcare system alike ...
Melissa, Ixcamey, Camille, Palma
+6 more sources
2010
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME.
Bandello, Francesco +6 more
+11 more sources
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME.
Bandello, Francesco +6 more
+11 more sources
Current Opinion in Ophthalmology, 2014
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Fabio, Patelli +2 more
+6 more sources
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Fabio, Patelli +2 more
+6 more sources
International Ophthalmology Clinics, 1976
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
A, Patz, S L, Fine
openaire +2 more sources
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
A, Patz, S L, Fine
openaire +2 more sources
Acta Ophthalmologica, 2022
AbstractThe main diabetic macular edema (DME) treatment options include intravitreal injections of anti‐VEGF agents and intravitreal injections of corticosteroids. In the past, macular laser photocoagulation (LP) was a standard of DME treatment, however, now it is utilized as an additional treatment. Two most important techniques of LP in patients with
openaire +2 more sources
AbstractThe main diabetic macular edema (DME) treatment options include intravitreal injections of anti‐VEGF agents and intravitreal injections of corticosteroids. In the past, macular laser photocoagulation (LP) was a standard of DME treatment, however, now it is utilized as an additional treatment. Two most important techniques of LP in patients with
openaire +2 more sources
European Journal of Ophthalmology, 1998
Retinal edema is defined as any increase of water in retinal tissue resulting in an increase in its volume. This increase may be initially intracellular or extracellular. In the first case, there is cytotoxic edema. In the second, vasogenic edema, directly associated with an alteration of the blood-retinal barrier (BRB).
openaire +3 more sources
Retinal edema is defined as any increase of water in retinal tissue resulting in an increase in its volume. This increase may be initially intracellular or extracellular. In the first case, there is cytotoxic edema. In the second, vasogenic edema, directly associated with an alteration of the blood-retinal barrier (BRB).
openaire +3 more sources